Coop recalls six food products over possible metal contamination risk
Coop recalls six food products over possible metal contamination risk
Coop recalls six food products over possible metal contamination risk
Coop has recalled multiple food items due to possible metal contamination. The affected products contain parsley and were sold exclusively on January 28, 2026. Customers have been warned not to consume them as they may pose a health risk.
The recall covers six products: Betty Bossi chopped parsley (20g), Freshly Made Protein Salad (325g), Betty Bossi Protein Salad (325g), Butterfly garlic shrimp (pre-packaged), Garlic shrimp with tails (pre-packaged), and Sunday roast (pre-packaged). All were available for purchase only on January 28, 2026.
These items were sold across Coop's retail network, including Coop supermarkets, Coop to go, Coop City department stores, Coop Pronto convenience stores, and Jumbo outlets. The company has not confirmed where the products were stored or removed from sale before being offered in these locations.
Coop has advised customers who bought any of the listed products to avoid eating them. The recall applies only to items purchased on the specified date. Further updates are expected if additional risks are identified.
Backpack Program quietly fights weekend hunger for Illinois children in need
A simple backpack changes everything for families like Leilani's. How 12 pounds of food each Friday is breaking the cycle of weekend hunger.
A Decade Inside Broadmoor: Life Among Britain's Most Dangerous Criminals
From daily routines with serial killers to rebuilding a shattered life, one man's journey reveals the brutal truth of Broadmoor. Could you survive a decade inside?
Algae-based foods may contain dangerous iodine levels without warnings
Your healthy algae snack could be a silent threat. Researchers expose alarming iodine levels in everyday foods—and why labels fail to protect you.
RHÖN-KLINIKUM AG reports record growth and €1.7B revenue in 2025
A year of breakthroughs: nearly a million patients served, cutting-edge tech deployed, and dividends on the horizon. What's next for this healthcare giant?